tiprankstipranks
Aerovate Therapeutics Announces Upcoming Investor Presentation Access
PremiumCompany AnnouncementsAerovate Therapeutics Announces Upcoming Investor Presentation Access
1M ago
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
PremiumPress Releases
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
1M ago
Aerovate Therapeutics price target raised to $50 from $27 at BTIG
PremiumThe Fly
Aerovate Therapeutics price target raised to $50 from $27 at BTIG
1M ago
Aerovate Therapeutics appoints Dable as board of directors
PremiumThe FlyAerovate Therapeutics appoints Dable as board of directors
2M ago
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
PremiumPress Releases
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
2M ago
Aerovate Therapeutics initiated with an Overweight at Wells Fargo
PremiumThe Fly
Aerovate Therapeutics initiated with an Overweight at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100